Eli Lilly & Co (LLY)

Eli Lilly & Co (LLY) Stock Price & Analysis


LLY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$307.17 - $628.81
Previous Close$584.04
Average Volume (3M)3.29M
Market Cap
Enterprise Value$572.19B
Total Cash (Recent Filing)$2.49B
Total Debt (Recent Filing)$20.17B
Price to Earnings (P/E)107.8
Feb 06, 2024
4.52 (0.77%)
Share Statistics
EPS (TTM)5.42
Shares Outstanding949,307,237
10 Day Avg. Volume2,629,729
30 Day Avg. Volume3,287,813
Standard Deviation0.08
Financial Highlights & Ratios
Price to Book (P/B)1568.41
Price to Sales (P/S)19.43
Price to Cash Flow (P/CF)63.30
P/FCF Ratio115.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue17.84
Enterprise Value/Gross Profit26.11
Enterprise Value/Ebitda72.59
Price Target Upside11.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20



Ownership Overview

10.90% Insiders
24.59% Mutual Funds
43.12% Other Institutional Investors
21.39% Public Companies and Individual Investors


What was Eli Lilly & Co’s price range in the past 12 months?
Eli Lilly & Co lowest stock price was $307.17 and its highest was $628.81 in the past 12 months.
    What is Eli Lilly & Co’s market cap?
    Currently, no data Available
    When is Eli Lilly & Co’s upcoming earnings report date?
    Eli Lilly & Co’s upcoming earnings report date is Feb 06, 2024 which is in 63 days.
      How were Eli Lilly & Co’s earnings last quarter?
      Eli Lilly & Co released its earnings results on Nov 02, 2023. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.179 by $0.279.
        Is Eli Lilly & Co overvalued?
        According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Eli Lilly & Co pay dividends?
          Eli Lilly & Co pays a Quarterly dividend of $1.13 which represents an annual dividend yield of 0.77%. See more information on Eli Lilly & Co dividends here
            What is Eli Lilly & Co’s EPS estimate?
            Eli Lilly & Co’s EPS estimate is $2.72.
              How many shares outstanding does Eli Lilly & Co have?
              Eli Lilly & Co has 949,307,250 shares outstanding.
                What happened to Eli Lilly & Co’s price movement after its last earnings report?
                Eli Lilly & Co reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.179. Following the earnings report the stock price went up 4.658%.
                  Which hedge fund is a major shareholder of Eli Lilly & Co?
                  Among the largest hedge funds holding Eli Lilly & Co’s share is PRIMECAP Management Co. It holds Eli Lilly & Co’s shares valued at 12B.


                    Company Description

                    Eli Lilly & Co

                    Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.


                    Top 5 ETFs holding LLY

                    Market Value
                    Smart Score
                    Global X S&P 500 Covered Call ETF
                    iShares ESG Screened S&P 500 ETF
                    Zacks Earnings Consistent Portfolio ETF
                    Global X S&P 500 Covered Call & Growth ETF
                    Global X S&P 500 ESG Covered Call ETF
                    Up to five ETFs with an Outperform Smart Score that hold LLY. The ETFs are listed according to market value of LLY within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Bristol-Myers Squibb
                    Merck & Company

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis